Plasma Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Obsessive Compulsive Disorder

Aim. Recent research implicated place of an immune mechanism in the pathophysiology of obsessive-compulsive disorder (OCD). Despite increasing evidence involvement of cytokine release in OCD, results of the studies are inconsistent. The aim of this study was to evaluate the plasma levels of the cytokines; tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in OCD patients. Methods. Plasma concentrations of TNF-α and IL-6 were measured in 31 drug-free outpatients with OCD, and 31-year age and sex-matched healthy controls. TNF-α and IL-6 concentrations in blood were determined by enzyme-linked immunosorbent assay (ELISA). Results. Both TNF-α and IL-6 levels showed statistically significant increases in OCD patients compared to controls (P < .000, P < .001, resp.). In addition, the age of onset was negatively correlated with TNF-α level (r = −.402, P = .025) and duration of illness was weakly correlated with IL-6 levels (r : .357; P : .048) in patients group. Conclusion. OCD patients showed increases in TNF-α and IL-6 levels compared to the healthy controls. This study provides evidence for alterations in the proinflamatory cytokines which suggest the involvement of the immune system in the pathophysiology of OCD.

[1]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[2]  R. Kravitz,et al.  Depression , 2007, Annals of Internal Medicine.

[3]  A. Murphy.  THE REDEMPTION: AN INTERDISCIPLINARY SYMPOSIUM ON CHRIST AS REDEEMER edited by Stephen T. Davies, Daniel Kendall SJ & Gerald O’ Collins SJ, Oxford University Press, 2004, Pp xxx + 351, £55.00 hbk. , 2006 .

[4]  W. Goodman,et al.  Immunology of obsessive-compulsive disorder. , 2006, The Psychiatric clinics of North America.

[5]  B. Leonard,et al.  Changes in the immune system in depression and dementia: causal or coincidental effects? , 2006, Dialogues in clinical neuroscience.

[6]  H. Westenberg,et al.  Decreased TNF-α and NK activity in obsessive-compulsive disorder , 2004, Psychoneuroendocrinology.

[7]  M. Bilici,et al.  The influence of olanzapine on immune cells in patients with schizophrenia , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  C. McDougle,et al.  Cerebrospinal fluid interleukin-6 in obsessive–compulsive disorder and trichotillomania , 2002, Psychiatry Research.

[9]  T. Pollmächer,et al.  In Vitro Cytokine Secretion in Individuals with Schizophrenia: Results, Confounding Factors, and Implications for Further Research , 2001, Brain, Behavior, and Immunity.

[10]  W. Goodman,et al.  Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function? , 2001, Seminars in clinical neuropsychiatry.

[11]  B. Leonard.  Changes in the immune system in depression and dementia: causal or co-incidental effects? , 2001, International Journal of Developmental Neuroscience.

[12]  J. Petitto,et al.  Brain-Immune Interactions in Neuropsychiatry: Highlights of the Basic Science and Relevance to Pathogenic Factors and Epiphenomena , 2001, CNS Spectrums.

[13]  M. Türkçapar,et al.  Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. , 2001, Comprehensive psychiatry.

[14]  C. Stefanis,et al.  Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients , 2001, Schizophrenia Research.

[15]  M. Maes.  The immunoregulatory effects of antidepressants , 2001, Human psychopharmacology.

[16]  A. Rabavilas,et al.  Olanzapine and obsessive–compulsive symptoms , 2000, European Neuropsychopharmacology.

[17]  H. Anisman,et al.  Synergistic Effects of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α: Central Monoamine, Corticosterone, and Behavioral Variations , 2000, Neuropsychopharmacology.

[18]  D. Remick,et al.  Cytokines and the brain: implications for clinical psychiatry. , 2000, The American journal of psychiatry.

[19]  H. Vedder,et al.  Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.

[20]  L. Bellodi,et al.  Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy , 1999, Psychiatry Research.

[21]  E. Bosmans,et al.  Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events , 1999, Biological Psychiatry.

[22]  K. Lesch,et al.  Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6 , 1998, Neurochemistry International.

[23]  M. Maj,et al.  Decreased Blood Levels of Tumor Necrosis Factor-Alpha in Patients with Obsessive-Compulsive Disorder , 1998, Neuropsychobiology.

[24]  G. Kollias,et al.  Exploratory and Displacement Behavior in Transgenic Mice Expressing High Levels of Brain TNF-α , 1998, Physiology & Behavior.

[25]  B. Leonard,et al.  Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.

[26]  L. Bellodi,et al.  Plasma Interleukin-1β and Tumor Necrosis Factor Concentrations in Obsessive–Compulsive Disorders , 1997, Biological Psychiatry.

[27]  J. Rapoport,et al.  Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. , 1997, Journal of immunology.

[28]  F. Zavala.  Benzodiazepines, anxiety and immunity. , 1997, Pharmacology & therapeutics.

[29]  H. Hermesh,et al.  Cytokine production in obsessive-compulsive disorder , 1996, Biological Psychiatry.

[30]  J. Rybakowski,et al.  Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine , 1995, Annals of the New York Academy of Sciences.

[31]  N. Rothwell,et al.  Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.

[32]  N. Rothwell,et al.  Cytokines and the nervous system I: expression and recognition , 1995, Trends in Neurosciences.

[33]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  F. Holsboer,et al.  Gene expression and function of interleukin I, interleukin 6 and tumor necrosis factor in the brain , 1994, Progress in Neurobiology.

[35]  Suck-Won Kim,et al.  The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.

[36]  F. Holsboer,et al.  Cellular Localization of Interleukin 6 mRNA and Interleukin 6 Receptor mRNA in Rat Brain , 1993, The European journal of neuroscience.

[37]  T. Kishimoto,et al.  Interleukin-6 and its receptor in autoimmunity. , 1992, Journal of autoimmunity.

[38]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.

[39]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[40]  M. Hamilton.  The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.

[41]  R. Tükel,et al.  Influence of age of onset on clinical features in obsessive–compulsive disorder , 2005, Depression and anxiety.

[42]  E. Hollander,et al.  Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. , 2004, The Journal of clinical psychiatry.

[43]  H. Anisman,et al.  Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. , 1999, Journal of affective disorders.

[44]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[45]  J. Rapoport,et al.  Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. , 1997, The American journal of psychiatry.

[46]  R. Weizman,et al.  T cell subsets in obsessive-compulsive disorder. , 1996, Neuropsychobiology.

[47]  H. Meltzer,et al.  Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. , 1994, Neuropsychobiology.

[48]  M. Stein,et al.  Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia. , 1994, Anxiety.

[49]  B. Rabin,et al.  Autoimmunity in schizophrenia: a review of recent findings. , 1993, Annals of medicine.

[50]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.